Aceragen, Inc.
ACGNDelisted Aug 16, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000861838
Aceragen, Inc. was delisted on Aug 16, 2023; its insiders filed their last Form 4 on Aug 11, 2023; 20 institutions reported holding it in 13F filings for Q2 2023, worth $269.5K in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Aceragen, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 48 | 47 | −1 |
| Shares | 6.34M | 6.21M | −130.9K (−2.1%) |
| Value | $7.60M | $6.39M | −$1.21M (−15.9%) |
New holders (4)
Institutions that held Aceragen, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 271,640 | $280.0K | 0.00% |
| DCM Advisors, LLC | 105,007 | $108.0K | 0.04% |
| FMR LLC | 471 | $0 | 0.00% |
| Meridian Wealth Partners, LLC | 45 | $0 | 0.00% |
Sold out (5)
Institutions that held Aceragen, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Virtu Financial LLC | 325,330 | $390.0K |
| Millennium Management LLC | 111,383 | $134.0K |
| Clear Creek Financial Management, LLC | 49,696 | $60.0K |
| JPMorgan Chase & Co | 481 | $1.00K |
| Panagora Asset Management Inc | 653 | $1.00K |